Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Drug Manufacturers — Specialty and Generic

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for companion and food animals. It offers companion animal disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks; companion animal therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production. The company sells its products to third-party distributors; veterinarians; and food animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. The company has a research and development collaboration with AgBiome, Inc. to develop nutritional health products for swine; and strategic alliance with the Purdue University and Purdue Research Foundation. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
Website: elanco.com



Growth: Pretty weak revenue growth rate 4.8%, there is slowdown compared to average historical growth rates 16.9%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -7.8%

Profitability: LTM EBITDA margin is positive, +14.8%. On average the margin is decreasing unsteadily. Gross margin is high, +50.1%. In the last quarter the company beat the estimated EPS, +55.2%. The company was ahead of estimated EPS in 100% of quarters (showing a gain of +$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 0.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 67.5% higher than minimum and 63.2% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 2.9x by EV / Sales multiple , the company can be 5.7% undervalued

Insiders: For the last 3 months insiders bought company shares on $0.6 mln (0.008% of cap.)

Key Financials (Download financials)

Ticker: ELAN
Share price, USD:  (+0.4%)13.53
year average price 12.43  


year start price 9.31 2023-05-07

min close price 8.08 2023-05-30

max close price 16.46 2024-02-27

current price 13.53 2024-05-05
Common stocks: 474 095 987

Dividend Yield:  0.0%
EV / LTM EBITDA: 18.5x
EV / EBITDA annualized: 10.6x
Last revenue growth (y/y):  4.8%
Last growth of EBITDA (y/y):  -11.2%
Historical revenue growth:  16.9%
Historical growth of EBITDA:  54.6%
EV / Sales: 2.7x
Margin (EBITDA LTM / Revenue): 14.8%
Fundamental value created in LTM:
Market Cap ($m): 6 415
Net Debt ($m): 5 695
EV (Enterprise Value): 12 110
Price to Book: 1.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-03-31Reuters

Activist investor Ancora secures two Elanco board seats, Bloomberg News reports

2024-03-11Schwab Network

Elanco Animal Health (ELAN) CEO on Pet Disease Prevention & Health Products

2024-02-26Zacks Investment Research

Here's What Key Metrics Tell Us About Elanco Animal Health Incorporated (ELAN) Q4 Earnings

2024-02-21Zacks Investment Research

Elanco Animal Health Incorporated (ELAN) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

2024-02-19Zacks Investment Research

Analysts Estimate Elanco Animal Health Incorporated (ELAN) to Report a Decline in Earnings: What to Look Out for

2024-02-05Proactive Investors

Elanco Animal Health sells aqua business to Merck for $1.3 billion

2024-02-05Market Watch

Elanco Animal Health agrees to sell aqua business to Merck for $1.3 billion in cash

2024-01-08Zacks Investment Research

Strength Seen in Elanco Animal Health Incorporated (ELAN): Can Its 6.2% Jump Turn into More Strength?

2024-01-05Invezz

Stifel: ‘party is just getting started' in this stock up 80%

2024-01-01Zacks Investment Research

Elanco Animal Health Incorporated (ELAN) Hit a 52 Week High, Can the Run Continue?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-07 2023-05-09 2023-03-01 2022-11-08
acceptedDate 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 1 035M 1 068M 1 057M 1 257M 988M 1 028M
costOfRevenue 516M 487M 434M 494M 448M 472M
grossProfit 519M 581M 623M 763M 540M 556M
grossProfitRatio 0.501 0.544 0.589 0.607 0.547 0.541
researchAndDevelopmentExpenses 79M 86M 81M 81M 80M 78M
generalAndAdministrativeExpenses 85M 0 0 0 0 0
sellingAndMarketingExpenses 207M 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 292M 313M 353M 327M 303M 298M
otherExpenses -34M -9M -23M 134M 130M 128M
operatingExpenses 509M 539M 570M 542M 513M 504M
costAndExpenses 1 025M 1 026M 1 004M 1 036M 961M 976M
interestIncome 0 72M 74M 0 0 0
interestExpense 67M 72M 74M 64M 62M 60M
depreciationAndAmortization 171M 140M 136M 134M 130M 167M
ebitda 147M 173M 166M 346M 136M 211M
ebitdaratio 0.142 0.162 0.157 0.275 0.138 0.205
operatingIncome -24M 42M 53M 212M 6M 44M
operatingIncomeRatio -0.023 0.039 0.050 0.169 0.006 0.043
totalOtherIncomeExpensesNet -70M -1 067M -58M -104M -94M -86M
incomeBeforeTax -127M -1 097M -79M 108M -88M -42M
incomeBeforeTaxRatio -0.123 -1.027 -0.075 0.086 -0.089 -0.041
incomeTaxExpense 14M -1 000 000 18M 5M -34M 7M
netIncome -141M -1 096M -97M 103M -54M -49M
netIncomeRatio -0.136 -1.026 -0.092 0.082 -0.055 -0.048
eps -0.290 -2.220 -0.200 0.210 -0.110 -0.100
epsdiluted -0.290 -2.220 -0.200 0.210 -0.110 -0.100
weightedAverageShsOut 493M 493M 493M 491M 489M 488M
weightedAverageShsOutDil 493M 493M 493M 493M 489M 488M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-07 2023-05-09 2023-03-01 2022-11-08
acceptedDate 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 352M 369M 367M 318M 345M 460M
shortTermInvestments 0 0 40M 0 0 0
cashAndShortTermInvestments 352M 369M 367M 318M 345M 460M
netReceivables 1 010M 1 135M 1 225M 1 264M 1 002M 1 028M
inventory 1 735M 1 690M 1 690M 1 596M 1 538M 1 340M
otherCurrentAssets 310M 371M 370M 370M 394M 326M
totalCurrentAssets 3 407M 3 565M 3 652M 3 548M 3 279M 3 154M
propertyPlantEquipmentNet 1 026M 992M 1 007M 1 000M 999M 936M
goodwill 5 094M 4 902M 6 040M 6 061M 5 993M 5 716M
intangibleAssets 4 494M 4 475M 4 678M 4 791M 4 842M 4 766M
goodwillAndIntangibleAssets 9 588M 9 377M 10 718M 10 852M 10 835M 10 482M
longTermInvestments 26M 60M 87M 0 0 0
taxAssets -26M -60M -87M 0 0 0
otherNonCurrentAssets 341M 410M 419M 369M 378M 376M
totalNonCurrentAssets 10 955M 10 779M 12 144M 12 221M 12 212M 11 794M
otherAssets 0 0 0 0 0 0
totalAssets 14 362M 14 344M 15 796M 15 769M 15 491M 14 948M
accountPayables 270M 296M 354M 381M 390M 350M
shortTermDebt 38M 39M 39M 381M 388M 394M
taxPayables 0 0 0 0 0 0
deferredRevenue 524M 356M 0 0 0 0
otherCurrentLiabilities 409M 574M 891M 816M 924M 869M
totalCurrentLiabilities 1 241M 1 265M 1 284M 1 578M 1 702M 1 613M
longTermDebt 5 736M 5 870M 6 023M 5 639M 5 448M 5 507M
deferredRevenueNonCurrent 184M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 567M 643M 658M 663M 662M 618M
otherNonCurrentLiabilities 411M 432M 411M 409M 390M 5 846M
totalNonCurrentLiabilities 6 898M 6 945M 7 092M 6 711M 6 500M 6 590M
otherLiabilities 0 0 0 0 0 0
capitalLeaseObligations 110M 0 0 0 0 0
totalLiabilities 8 139M 8 210M 8 376M 8 289M 8 202M 8 203M
preferredStock 0 0 0 0 0 0
commonStock 0 0 0 0 0 0
retainedEarnings -2 288M -2 147M -1 051M -954M -1 057M -972M
accumulatedOtherComprehensiveIncomeLoss -266M -482M -281M -310M -392M -1 007M
othertotalStockholdersEquity 8 777M 8 763M 8 752M 8 744M 8 738M 8 724M
totalStockholdersEquity 6 223M 6 134M 7 420M 7 480M 7 289M 6 745M
totalEquity 6 223M 6 134M 7 420M 7 480M 7 289M 6 745M
totalLiabilitiesAndStockholdersEquity 14 362M 14 344M 15 796M 15 769M 15 491M 14 948M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 14 362M 14 344M 15 796M 15 769M 15 491M 14 948M
totalInvestments 26M 60M 87M 0 0 0
totalDebt 5 774M 5 909M 6 062M 6 020M 5 836M 5 901M
netDebt 5 422M 5 540M 5 695M 5 702M 5 491M 5 441M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol ELAN ELAN ELAN ELAN ELAN ELAN
reportedCurrency USD USD USD USD USD USD
cik 2M 2M 2M 2M 2M 2M
fillingDate 2024-02-26 2023-11-07 2023-08-07 2023-05-09 2023-03-01 2022-11-08
acceptedDate 2024-02-26 09:05:25 2023-11-07 16:14:47 2023-08-07 16:11:14 2023-05-09 09:08:41 2023-03-01 13:00:26 2022-11-08 09:07:49
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome -141M -1 096M -97M 103M -55M -49M
depreciationAndAmortization 171M 173M 177M 173M 168M 167M
deferredIncomeTax -53M 1 047M -3M 2M -21M 4M
stockBasedCompensation 15M 10M 9M 12M 15M 13M
changeInWorkingCapital 146M 27M -34M -439M -78M -15M
accountsReceivables -40M 0 0 0 14M 0
inventory -160M 0 0 0 -269M 0
accountsPayables 200M 0 0 0 -98M 0
otherWorkingCapital 146M 27M -34M 0 275M 0
otherNonCashItems 19M 37M 9M 4M -16M 69M
netCashProvidedByOperatingActivities 157M 198M 61M -145M 13M 189M
investmentsInPropertyPlantAndEquipment -41M -33M -42M -38M -79M -46M
acquisitionsNet 0 -3M 0 -16M 2M 11M
purchasesOfInvestments 0 0 0 0 0 0
salesMaturitiesOfInvestments 0 0 0 0 0 0
otherInvestingActivites 6M 0 -1 000 000 -1 000 000 1 000 000 -2M
netCashUsedForInvestingActivites -35M -36M -43M -55M -76M -37M
debtRepayment -139M -506M -13M -19M -70M -154M
commonStockIssued 0 0 0 0 0 0
commonStockRepurchased 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 0 349M 52M 193M -14M -15M
netCashUsedProvidedByFinancingActivities -139M -157M 39M 174M -84M -169M
effectOfForexChangesOnCash 0 -3M -8M -1 000 000 32M -30M
netChangeInCash -17M 2M 49M -27M -115M -47M
cashAtEndOfPeriod 352M 369M 367M 318M 345M 460M
cashAtBeginningOfPeriod 369M 367M 318M 345M 460M 507M
operatingCashFlow 157M 198M 61M -145M 13M 189M
capitalExpenditure -41M -33M -42M -38M -79M -46M
freeCashFlow 116M 165M 19M -183M -66M 143M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-26 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-07 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-21 ET (fiscal 2022 q4)
2022 q3
2022-11-08 ET (fiscal 2022 q3)
2022 q2
2022-08-08 ET (fiscal 2022 q2)
2022 q1
2022-05-09 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-26 11:27 ET
Elanco Animal Health Reports Fourth Quarter and Full Year 2023 Results
2024-02-22 13:00 ET
Elanco to Participate in Upcoming Investor Conferences
2024-02-08 19:46 ET
Beef 'agtech' company Cattler launches interface with Elanco for its Benchmark program
2024-02-08 13:00 ET
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2023 Financial Results Announcement
2024-02-05 11:33 ET
Merck Animal Health to Acquire Elanco’s Aqua Business
2024-02-05 11:33 ET
Elanco Announces Sale of Aqua Business for $1.3 Billion
2024-01-31 15:05 ET
Tonisity and Elanco Announce Receipt of Permission from the Japanese Government for Tonisity Px Import and Sales
2024-01-17 13:30 ET
Elanco Launches Multi-Year Mission to Save 1 Million Puppies from Canine Parvovirus
2024-01-16 19:29 ET
2024 Feather in Her Cap and High Flyer Award Winners Named for Outstanding Achievements in Animal Health Industry
2024-01-02 13:33 ET
Elanco Animal Health Announces Planned Board Leadership Changes and Corporate Governance Actions
2023-12-19 13:00 ET
Elanco to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-08 14:00 ET
Alveolus Bio Enters Into Strategic Collaboration with BiomEdit
2023-11-27 13:00 ET
Elanco to Participate in Evercore ISI 6th Annual HealthCONx Conference
2023-11-07 11:33 ET
Elanco Animal Health Reports Third Quarter 2023 Results
2023-11-02 11:16 ET
Athian and Elanco Animal Health Team Up to Transform Food Production through Methane Reduction
2023-10-17 12:00 ET
Elanco Confirms Date and Conference Call for Third Quarter 2023 Financial Results Announcement
2023-10-04 10:30 ET
Elanco Announces Corporate Governance Enhancements
2023-09-07 20:15 ET
Elanco Launches Varenzin™-CA1 (molidustat oral suspension) – the First-of-its-Kind Oral Treatment for Anemia in Cats with Chronic Kidney Disease
2023-09-05 21:00 ET
Elanco to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-07 10:33 ET
Elanco Animal Health Reports Second Quarter 2023 Results and Raises Full Year Guidance
2023-07-20 12:00 ET
Elanco Releases 2022 Environmental, Social and Governance Report, Demonstrating Sustainability Progress in Internal Operations and Customer Collaborations
2023-07-18 12:00 ET
Elanco Confirms Date and Conference Call for Second Quarter 2023 Financial Results Announcement
2023-07-13 21:24 ET
Environmental Protection Agency (EPA) Completes Review of Seresto® Collar and Confirms Continued Registration; Data Affirms Safety Profile of the Product
2023-07-04 14:23 ET
Elanco and Tonisity International Expand Strategic Partnership into The Philippines
2023-06-05 12:00 ET
Elanco to Participate in Goldman Sachs 44th Annual Global Healthcare Conference
2023-05-25 12:00 ET
Elanco to Participate in Stifel 2023 Jaws and Paws Conference
2023-05-19 11:53 ET
Elanco to Begin Distributing Tonisity's Gut Enhancing Swine Products Following Strategic Partnership Agreement
2023-05-09 10:34 ET
Elanco Animal Health Reports First Quarter 2023 Results
2023-05-02 12:30 ET
Elanco Announces Breakthrough Treatment for Deadly Canine Parvovirus
2023-05-01 23:35 ET
California Dairies, Inc. and DSM Venturing Complete Strategic Investment in Athian
2023-04-18 12:00 ET
Elanco Confirms Date and Conference Call for First Quarter 2023 Financial Results Announcement
2023-03-14 12:00 ET
Tyson Ventures invests in Athian's cloud-based carbon credit marketplace for livestock sector
2023-03-09 13:00 ET
Elanco to Participate in the Barclays Global Healthcare Conference
2023-02-27 13:00 ET
Elanco to Participate in the Cowen 43rd Annual Health Care Conference
2023-02-23 21:45 ET
Elanco to Participate in the Bank of America 2023 Animal Health Summit
2023-02-21 11:30 ET
Elanco Animal Health Reports Fourth Quarter and Full Year 2022 Results
2023-02-20 21:30 ET
Elanco Adds Animal Health Veteran to Executive Committee
2023-02-03 13:30 ET
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2022 Financial Results Announcement
2023-01-03 13:00 ET
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference
2022-12-09 15:48 ET
Elanco Announces FDA Approval of Bexacat™ (bexagliflozin tablets) – the First-of-its-Kind Oral Feline Diabetes Treatment Option
2022-11-16 13:00 ET
Elanco to Participate in Evercore ISI 5th Annual HealthCONx Conference
2022-11-15 20:48 ET
Elanco and Tonisity International Form Strategic Partnership Regarding Tonisity's Gut Enhancing Swine Products
2022-11-08 11:30 ET
Elanco Animal Health Reports Third Quarter 2022 Results
2022-10-11 12:00 ET
Elanco Confirms Date and Conference Call for Third Quarter 2022 Financial Results Announcement
2022-09-08 12:00 ET
Elanco Announces Changes to its Board of Directors
2022-09-01 12:00 ET
Elanco to Participate in Morgan Stanley 20th Annual Global Healthcare Conference
2022-08-16 12:00 ET
Elanco Releases 2021 Environmental, Social and Governance Report Highlighting Progress on Healthy Purpose™ Goals
2022-08-08 10:30 ET
Elanco Animal Health Reports Second Quarter 2022 Results
2022-07-18 10:30 ET
Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement
2022-07-12 15:25 ET
Elanco Survey Finds Many Pets Live Unprotected Against Preventable Diseases
2022-06-07 11:30 ET
New Anthem from Seresto Could be the 2022 Song of the Summer
2022-06-06 10:30 ET
Elanco to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
2022-05-23 10:30 ET
Elanco to Participate in Stifel 2022 Jaws and Paws Conference
2022-05-09 10:30 ET
Elanco Animal Health Reports First Quarter 2022 Results
2022-04-27 05:00 ET
Elanco and Royal DSM Announce Strategic Alliance in U.S. for Bovaer® – A Revolutionary, Methane-Reducing Feed Product for Cattle
2022-04-14 10:30 ET
Elanco Confirms Date and Conference Call for First Quarter 2022 Financial Results Announcement
2022-04-12 14:30 ET
Elanco Breaks Ground on State-of-the-Art Campus, Creating Indianapolis’ Newest Landmark
2022-04-12 10:30 ET
Elanco Animal Health Incorporated Announces Early Results of Tender Offer and Increase in Tender Cap for 2023 Notes
2022-04-11 11:00 ET
Elanco and Ginkgo Bioworks Launch BiomEdit, a New Animal Health Company Leveraging Microbiome Technology
2022-03-29 21:57 ET
Elanco Animal Health Incorporated Announces Tender Offer for 2023 Notes
2022-03-16 12:30 ET
Elanco Expands Commitment to Creating Shared Value, Launches New Initiative Empowering Small-Scale Producers in Sub-Saharan Africa
2022-02-24 11:30 ET
Elanco Animal Health Reports Fourth Quarter and Full Year 2021 Results
2022-02-22 21:35 ET
Elanco Announces the Addition of Rajeev (Bobby) Modi to Lead U.S. Pet Health
2022-02-21 11:30 ET
Elanco to Participate in the Cowen 42nd Annual Health Care Conference
2022-02-08 17:10 ET
TriRx Completes Acquisition of Elanco Manufacturing Facility in Speke, United Kingdom
2022-02-07 13:30 ET
Elanco Adds New Tools to Advance U.S. Livestock Sustainability Efforts
2022-02-04 11:30 ET
Elanco to Participate in the BofA Securities 2022 Virtual Animal Health Summit
2022-02-03 11:30 ET
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2021 Financial Results Announcement
2022-01-20 21:30 ET
Elanco’s ZORBIUM™ (Buprenorphine Transdermal Solution) – the First Long-Acting Transdermal Buprenorphine for Cats - Gains U.S. Approval
2022-01-04 21:30 ET
Elanco to Participate in the 40th Annual J.P. Morgan Healthcare Conference
2021-11-30 12:00 ET
Elanco Announces Changes to Simplify Organizational Structure, Drive Profitable Growth and Focus Investments on Growth and Innovation Opportunities
2021-11-16 13:30 ET
Elanco to Participate in the Evercore ISI 4th Annual HealthCONx Conference
2021-11-08 14:00 ET
Elanco Joins Newly-Formed Consortium Advancing Climate-Neutral Cattle Innovation
2021-11-05 10:30 ET
Elanco Animal Health Reports Third Quarter 2021 Results Exceeding Revenue Guidance; Raising Full Year 2021 Revenue Guidance
2021-10-18 20:15 ET
Elanco Animal Health Selected for 2021 FORTUNE’s Change the World List
2021-10-07 12:30 ET
Elanco Confirms Date and Conference Call for Third Quarter 2021 Financial Results Announcement
2021-10-05 10:30 ET
Elanco Announces New Innovation Leader, Additional Strategic Move to Increase Focus on High-Value, Late-Stage Pet Health Pipeline Progress
2021-09-29 12:30 ET
Climate-Neutral Beef, Dairy Could Reach Store Shelves by 2050, According to New Research
2021-09-22 20:15 ET
Animal Agriculture Accepts Challenge to Be Climate Change Solution while Delivering Global Nutrition Needs
2021-09-16 17:00 ET
Business Leaders, Global Experts Convene in Effort to Move Livestock Production to Climate-Neutrality and Achieve Zero Hunger
2021-08-30 10:45 ET
Elanco Closes Acquisition of Kindred Biosciences
2021-08-25 12:30 ET
Elanco to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference
2021-08-11 06:00 ET
TriRx Hosted State and Community Leaders to Celebrate Acquisition of Shawnee, Kansas Facility
2021-08-10 12:15 ET
(ELAN) Elanco Animal Health Alert: Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Investigation
2021-08-09 10:30 ET
Elanco Animal Health Reports Second Quarter 2021 Results
2021-08-02 06:00 ET
TriRx Completes Acquisition of Elanco Animal Health Facility in Shawnee, Kansas
2021-07-21 12:04 ET
Akshaya Patra Partners with the Elanco Foundation to Receive $100,000 for COVID-19 Food Relief Efforts across India.
2021-07-12 12:30 ET
Elanco Confirms Date and Conference Call for Second Quarter 2021 Financial Results Announcement
2021-06-30 20:30 ET
Elanco Foundation Announces Partnership with the JBS Fund
2021-06-16 10:30 ET
Elanco Announces Agreement to Acquire Kindred Biosciences
2021-06-16 10:30 ET
Elanco Announces Agreement to Acquire Kindred Biosciences
2021-06-15 06:00 ET
TriRx Enters Agreement for the Acquisition of Elanco Animal Health Facilities in Shawnee, Kansas and Speke, United Kingdom
2021-06-10 10:30 ET
Elanco Releases Environmental, Social and Governance (ESG) Summary
2021-06-09 13:15 ET
Elanco Announces Exit of Three Manufacturing Sites, Streamlining Footprint
2021-06-04 12:00 ET
Elanco Announces Addition of Marcela A. Kirberger as General Counsel and Corporate Secretary
2021-06-02 12:31 ET
Kindred Biosciences Announces Positive Results from Pivotal Efficacy Study of Parvovirus Monoclonal Antibody for the Prevention of Deaths in Dogs Infected by Parvovirus
2021-05-20 21:00 ET
Elanco to Participate in Upcoming Investor Conferences
2021-05-11 12:00 ET
Elanco Launches Product for U.S. Poultry Producers, Providing a Flexible Option for Cocci Control
2021-05-07 10:30 ET
Elanco Animal Health Reports First Quarter 2021 Results
2021-05-04 12:00 ET
Elanco Animal Health Introduces First Oral Flea and Tick Product for Cats, Credelio® CAT (lotilaner)
2021-04-28 12:32 ET
Kindred Biosciences Announces Acceptance of Parvovirus Antibody Prophylaxis Study Data and Approval of Efficacy Indication
2021-04-21 20:30 ET
Elanco Animal Health and Ducks Unlimited Announce Partnership to Advance Beef Industry Environmental Stewardship Efforts
2021-04-07 12:30 ET
Elanco Confirms Date and Conference Call for First Quarter 2021 Financial Results Announcement
2021-03-19 10:30 ET
Elanco Stands Behind Seresto and its Safety Profile
2021-03-19 09:00 ET
Morris Animal Foundation Partners with Elanco to Improve Understanding of Canine Osteoarthritis
2021-02-24 11:30 ET
Elanco Animal Health Reports Fourth Quarter and Full Year 2020 Results
2021-02-22 13:00 ET
Elanco General Counsel Michael-Bryant Hicks to Depart After Successful Company Stand-Up and Acquisition Completion
2021-02-19 13:00 ET
Elanco Achieves Important Innovation Milestones, Momentum to Start 2021
2021-02-18 13:30 ET
Elanco to Participate in the Cowen 41st Annual Health Care Conference
2021-02-12 13:30 ET
Elanco to Participate in the BofA Securities Animal Health Virtual Summit
2021-01-27 13:30 ET
Elanco Confirms Date and Conference Call for Fourth Quarter 2020 Financial Results Announcement
2021-01-26 13:00 ET
Elanco Announces Next Wave of Restructuring to Drive Operational Efficiencies Post Bayer Acquisition
2021-01-19 13:00 ET
Dr. Marijn Dekkers Named Chairman of AgBiome Board of Directors
2021-01-11 12:00 ET
Elanco Begins Next Phase of Integration Post-Bayer Animal Health Acquisition; Executive Committee Member Sarena Lin to Depart
2020-12-22 13:30 ET
Elanco to Participate in the 39th Annual J.P. Morgan Healthcare Conference
2020-12-15 13:00 ET
Elanco Animal Health Hosts Investor Day, Demonstrating Inflection Point Toward Accelerated Value Creation
2020-12-14 21:05 ET
Elanco Appoints New Independent Directors to the Board and Expands Innovation and Operational Oversight
2020-12-11 13:00 ET
Elanco Announces Agreement with KindredBio to Bring First-of-its-Kind Canine Parvovirus Therapy to Market
2020-12-11 13:00 ET
Kindred Biosciences Announces Agreement Granting Elanco Exclusive Global Rights for its Parvovirus Monoclonal Antibody
2020-12-04 12:30 ET
Elanco Animal Health Selects Indiana as Home for Global HQ and Future Footprint Consolidation
2020-12-01 13:30 ET
Elanco to Host Virtual Investor Day, Provide 2021 Guidance
2020-11-30 12:00 ET
Elanco Announces Public Offering of Common Stock by Selling Shareholder
2020-11-19 13:30 ET
Elanco to Participate in the 3rd Annual Evercore ISI Virtual HealthCONx Conference
2020-11-06 11:30 ET
Elanco Animal Health Reports Third Quarter 2020 Results
2020-10-29 12:00 ET
Elanco to Participate in the Credit Suisse 29th Annual Virtual Healthcare Conference
2020-10-28 12:00 ET
Elanco’s Elura™ (capromorelin oral solution) Gains U.S. Approval
2020-10-27 12:00 ET
Elanco Releases Healthy Purpose™ 2030 Sustainability Commitments to Improve Health of Animals, People and Planet
2020-10-13 19:00 ET
Elanco Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation
2020-10-09 12:30 ET
Elanco Confirms Date and Conference Call for Third Quarter 2020 Financial Results Announcement
2020-09-30 11:30 ET
Elanco Announces Restructuring to Drive Synergies From Bayer Animal Health Acquisition
2020-09-08 21:00 ET
Elanco to Participate in the Morgan Stanley 18th Annual Global Healthcare Conference
2020-08-12 13:00 ET
Dr. Marijn Dekkers Joins AgBiome As a Strategic Advisor
2020-08-03 10:00 ET
Elanco Closes Acquisition of Bayer Animal Health
2020-07-30 10:30 ET
Elanco Animal Health Reports 2020 Second Quarter Results
2020-07-28 14:00 ET
Jason Kuhlemeier Joins AgBiome as VP of Marketing
2020-07-21 14:00 ET
Gerald Coward Joins AgBiome as CFO
2020-07-18 12:57 ET
LEGAL DEADLINE ALERT—The Law Firm of Barbuto & Johansson, P.A. Reminds R, ELAN, FSCT and ENPH Shareholders of Important Class Action Deadlines
2020-07-16 12:30 ET
First-of-its-Kind Study Shows 1 in 5 Dogs Visiting Dog Parks in Major U.S. Cities Tested Positive for Intestinal Parasites
2020-07-15 15:07 ET
Elanco Receives U.S. Federal Trade Commission Approval for Acquisition of Bayer Animal Health
2020-07-11 15:48 ET
LEGAL DEADLINE ALERT—The Law Firm of Barbuto & Johansson, P.A. Reminds LOPE, R, ELAN and WFC Shareholders of Important Class Action Deadlines
2020-07-08 12:30 ET
Elanco Confirms Date and Conference Call for Second Quarter 2020 Financial Results Announcement
2020-07-06 06:40 ET
LEGAL DEADLINE ALERT—The Law Firm of Barbuto & Johansson, P.A. Reminds LOPE, R, ELAN and WFC Shareholders of Important Class Action Deadlines
2020-06-08 14:45 ET
Elanco Announces European Commission Approval of Pending Acquisition of Bayer Animal Health
2020-06-03 12:30 ET
Elanco to Participate in Goldman Sachs 41st Annual Global Healthcare Conference
2020-05-28 12:30 ET
Elanco Helps More Than 1.4 Million Households and 293 Communities Become More Food Secure, Nearly Tripling Goal
2020-05-12 12:52 ET
Elanco to Participate in the Bank of America Securities Health Care Conference
2020-05-07 10:30 ET
Elanco Animal Health Reports 2020 First Quarter Results
2020-04-20 12:30 ET
Elanco Expands Executive Team to Lead Company Post Bayer Animal Health Acquisition
2020-04-14 15:00 ET
Elanco Animal Health Submits Form CO to European Commission
2020-04-09 12:00 ET
Elanco, VetNOW Collaborate to Expand Access to Veterinary Care, Relieve Impact of COVID-19
2020-04-07 12:30 ET
Elanco Confirms Date and Conference Call for First Quarter 2020 Financial Results Announcement
2020-03-27 12:30 ET
The Elanco Foundation Announces Efforts to Support Food Security Amidst COVID-19 Crisis
2020-03-24 10:29 ET
Elanco Provides Business Update Related to COVID-19
2020-02-27 13:30 ET
Elanco to Participate in Cowen Health Care Conference
2020-02-21 13:30 ET
Elanco to Participate in the Bank of America Merrill Lynch Animal Health Summit
2020-02-19 21:30 ET
Elanco Signs Agreement with Merck Animal Health to Divest Worldwide Rights for Vecoxan®
2020-02-19 11:29 ET
Elanco Animal Health Reports 2019 Fourth Quarter and Full Year Results
2020-02-17 13:35 ET
Elanco’s East Africa Growth Accelerator Delivers $8+ Million in Socio-Economic Value for Smallholder Farmers in East Africa, Progress Against Sustainable Development Goals
2020-02-12 21:30 ET
Elanco Signs Agreement with Vetoquinol to Divest Rights for Drontal® and Profender® Within the European Economic Area and the United Kingdom
2020-02-04 22:15 ET
Elanco Animal Health Announces Pricing and Upsize of Senior Secured Term Loan Facilities
2020-02-04 14:00 ET
Elanco Animal Health Announces Strategic Alliance With Purdue University and Purdue Research Foundation
2020-01-28 21:30 ET
Elanco Confirms Date and Conference Call for 2019 Fourth Quarter Financial Results
2020-01-23 11:00 ET
Elanco Animal Health Announces Upsizing and Pricing of Common Stock and Pricing of Tangible Equity Unit Offerings
2020-01-21 21:37 ET
Elanco Animal Health Announces Common Stock and Tangible Equity Unit Offerings Associated with Financing Acquisition of Bayer’s Animal Health Business
2020-01-13 13:00 ET
Elanco Signs Agreement with PetIQ to Divest Capstar®
2020-01-10 11:30 ET
Elanco Announces 2020 Financial Guidance
2020-01-08 22:00 ET
Elanco Confirms Date for 2020 Financial Guidance Announcement
2020-01-06 07:00 ET
Elanco Signs Agreement with Dechra to Divest Osurnia®
2020-01-03 13:30 ET
Elanco to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-24 12:30 ET
 Elanco Sells Victoria, PEI, Canada R&D Facility to The Center for Aquaculture Technologies Canada (CATC)
2019-12-09 21:30 ET
Elanco Animal Health Receives Second Request from FTC Under HSR Act
2019-12-02 21:30 ET
Elanco Animal Health Appoints Chief Sustainability Officer, Emphasizes Continued Commitment to Advance Well-Being of Animals, People and Planet
2019-11-06 11:30 ET
Elanco Animal Health Reports Third Quarter Results
2019-03-13 12:48 ET
Lilly Announces Final Results of Elanco Exchange Offer
2019-03-11 10:45 ET
Lilly Announces Preliminary Results of Elanco Exchange Offer
2019-03-07 11:45 ET
Lilly Announces Final Exchange Ratio of 4.5121 for Elanco Exchange Offer

SEC forms

Show financial reports only

SEC form 10
2024-02-26 09:05 ET
Elanco Animal Health published news for 2023 q4
SEC form 8
2024-02-26 06:30 ET
Elanco Animal Health published news for 2023 q4
SEC form 8
2024-02-26 06:30 ET
Elanco Animal Health reported for 2023 q4
SEC form 10
2024-02-26 00:00 ET
Elanco Animal Health published news for 2023 q4
SEC form 10
2023-11-07 16:14 ET
Elanco Animal Health published news for 2023 q3
SEC form 8
2023-11-07 06:29 ET
Elanco Animal Health reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Elanco Animal Health published news for 2023 q3
SEC form 10
2023-08-07 16:11 ET
Elanco Animal Health reported for 2023 q2
SEC form 6
2023-08-07 06:30 ET
Elanco Animal Health published news for 2023 q2
SEC form 10
2023-08-07 00:00 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-13 17:27 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-10 16:15 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-05 17:12 ET
Elanco Animal Health published news for 2023 q2
SEC form 6
2023-07-05 17:05 ET
Elanco Animal Health published news for 2023 q2
SEC form 10
2023-05-09 00:00 ET
Elanco Animal Health published news for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Elanco Animal Health published news for 2023 q1
SEC form 6
2023-03-24 16:03 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:10 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:08 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:07 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:06 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 21:00 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:59 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:59 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-03-03 20:55 ET
Elanco Animal Health published news for 2022 q4
SEC form 10
2023-03-01 13:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-03-01 12:39 ET
Elanco Animal Health published news for 2022 q4
SEC form 10
2023-03-01 00:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-02-21 06:30 ET
Elanco Animal Health published news for 2022 q4
SEC form 8
2023-02-21 00:00 ET
Elanco Animal Health reported for 2022 q4
SEC form 6
2023-02-03 16:06 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-31 16:05 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-09 08:01 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2023-01-05 18:32 ET
Elanco Animal Health published news for 2022 q4
SEC form 6
2022-12-02 17:12 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:10 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:08 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:06 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:05 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-12-02 17:04 ET
Elanco Animal Health published news for 2022 q3
SEC form 10
2022-11-08 09:07 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-11-08 06:57 ET
Elanco Animal Health published news for 2022 q3
SEC form 10
2022-11-08 00:00 ET
Elanco Animal Health reported for 2022 q3
SEC form 8
2022-11-08 00:00 ET
Elanco Animal Health reported for 2022 q3
SEC form 6
2022-11-03 18:45 ET
Elanco Animal Health published news for 2022 q3
SEC form 6
2022-09-08 08:05 ET
Elanco Animal Health published news for 2022 q2
SEC form 10
2022-08-08 09:05 ET
Elanco Animal Health published news for 2022 q2
SEC form 6
2022-08-08 07:00 ET
Elanco Animal Health published news for 2022 q2
SEC form 10
2022-08-08 00:00 ET
Elanco Animal Health reported for 2022 q2
SEC form 8
2022-08-08 00:00 ET
Elanco Animal Health reported for 2022 q2
SEC form 6
2022-07-06 18:03 ET
Elanco Animal Health published news for 2022 q2
SEC form 6
2022-06-29 16:15 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-05-19 17:01 ET
Elanco Animal Health published news for 2022 q1
SEC form 10
2022-05-09 09:08 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-05-09 07:01 ET
Elanco Animal Health published news for 2022 q1
SEC form 8
2022-05-09 00:00 ET
Elanco Animal Health reported for 2022 q1
SEC form 10
2022-05-09 00:00 ET
Elanco Animal Health reported for 2022 q1
SEC form 6
2022-04-20 16:11 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-13 06:15 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-06 16:17 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-04-05 18:03 ET
Elanco Animal Health published news for 2022 q1
SEC form 6
2022-03-29 17:13 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-24 16:14 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 21:03 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 21:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-03-03 16:05 ET
Elanco Animal Health published news for 2021 q4
SEC form 10
2022-02-28 14:46 ET
Elanco Animal Health published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-02-24 06:31 ET
Elanco Animal Health published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-14 08:13 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-10 06:16 ET
Elanco Animal Health published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2022-01-06 16:16 ET
Elanco Animal Health published news for 2021 q4
SEC form 6
2021-11-30 07:10 ET
Elanco Animal Health published news for 2021 q3
SEC form 10
2021-11-05 08:58 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-11-05 06:40 ET
Elanco Animal Health published news for 2021 q3
SEC form 8
2021-11-05 00:00 ET
Elanco Animal Health published news for 2021 q3
SEC form 10
2021-11-05 00:00 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-10-05 06:36 ET
Elanco Animal Health published news for 2021 q3
SEC form 6
2021-08-30 09:01 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-12 16:49 ET
Elanco Animal Health published news for 2021 q2
SEC form 10
2021-08-09 09:11 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-09 06:48 ET
Elanco Animal Health published news for 2021 q2
SEC form 8
2021-08-09 00:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 10
2021-08-09 00:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-08-02 09:03 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-07-01 09:00 ET
Elanco Animal Health published news for 2021 q2
SEC form 6
2021-06-16 07:01 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-06-09 16:10 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-06-04 08:10 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-21 16:02 ET
Elanco Animal Health published news for 2021 q1
SEC form 10
2021-05-07 09:11 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-07 06:42 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-05-07 06:40 ET
Elanco Animal Health published news for 2021 q1
SEC form 8
2021-05-07 00:00 ET
Elanco Animal Health published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Elanco Animal Health published news for 2021 q1
SEC form 6
2021-03-25 16:26 ET
Elanco Animal Health published news for 2020 q4
SEC form 10
2021-03-01 14:25 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-02-24 06:45 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-02-22 17:48 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-01-26 08:19 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2021-01-11 15:20 ET
Elanco Animal Health published news for 2020 q4
SEC form 6
2020-12-17 16:40 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-15 08:07 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-15 06:02 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-03 16:11 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-12-01 06:09 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-30 07:20 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-23 16:10 ET
Elanco Animal Health published news for 2020 q3
SEC form 10
2020-11-06 16:12 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-11-06 06:39 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-10-15 16:47 ET
Elanco Animal Health published news for 2020 q3
SEC form 6
2020-09-30 07:37 ET
Elanco Animal Health published news for 2020 q2